CDKN2A gene codes for cell cycle inhibitors, p16 signalling and SMAD4, which act as transducers of the transforming growth factor beta (TGF-β) signalling pathway, and are two commonly mutated tumor suppressors found in about 20% of PDAC cases (52). This evidence concerns the gene CDKN2A and neoplasm.